ASND

HoldPremium Grower

Ascendis Pharma A/S · Healthcare · Denmark · $16.3B · Avg Vol: $161M/d

Premium Grower: Strong business with the market behind it, but you are paying up for it.

54
StockRank
Get insider-trade alerts
Quality
66
Value
24
Momentum
57
P/E (TTM)
18.3x
peers 18.5x
ROE
118.8%
peers 15.9%
D/E
0.3x
peers 0.5x
Dividend %
—
trailing yield
Director trades · 180d
+$777.1K · −$5.5M →
bought · sold by directors
Buybacks · 180d
None →

ABOUT ASCENDIS PHARMA A/S

Read

Ascendis Pharma A/S is a biopharmaceutical company focused on developing innovative prodrug therapies for rare diseases using its proprietary TransCon technology platform. Its competitive moat is derived from this unique and versatile technology, which enables the creation of sustained-release drug candidates with improved efficacy and safety profiles. The company is a specialized biotech firm, aiming to redefine standards of care for patients with significant unmet medical needs.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026EFwd CAGR
Revenue58.8M306.5M417.8M827.5M141.4%1.2B1.6B89.9%
EPS-11.95-9.82-7.50-4.32—12.91——
Shares57.2M56.6M59.8M61.4M+7.4%65.8M——
Debt584.1M740.3M984.3M1.0B19.7%516.6M——
Equity302.6M-167.4M-121.5M-187.1M————
Op CF-569.6M-537.0M-351.8M61.9M—401.2M——
Inv CF70.9M329.2M7.9M-9.7M————
Fin CF455.9M154.3M510.1M41.7M————
Loading 1Y...
PRICE (1Y)-7.3%
237245254263271Aug 7Aug 28Sep 18
SMA 50SMA 200

Close
$236.72
RSI (14)
43.6
52W High
$282.15
From 52W High
0.8%

SCORE BREAKDOWN

Quality
66
ROIC
-56.6%14.0
ROE
118.8%99.5
GP/Assets
84.2%96.7
Op. Margin
65.0%99.0
FCF/Assets
10.4%87.6
Piotroski
549.1
Int. Cover
-1.6x32.1
D/E Ratio
0.31x40.4
Current Ratio
2.99x55.4
Value
24
P/E (TTM)
18.3x63.9
EV/EBITDA
50.7x11.2
P/FCF
120.3x14.8
P/B
51.5x1.7
P/S
13.0x21.3
Div Yield
—N/A
Momentum
57
52W High %
84%75.0
RS 6M
-11%52.9
SMA 50/200
1.09x73.9
EPS Rev 4W
+3.1%84.4
EPS Rev 12W
+1.9%71.9
EPS Improve
-15%16.3
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$16.3B
P/E (Forward)
21.5x
Gross Margin
91.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ASND are excluded.

TickerCompanyMkt CapStockRankSignal
ASNDAscendis Pharma A/S(you)$16.3B54Hold
GMABGenmab A/S$20.4B65Buy
ALK-B.COALK-Abelló A/S$7.2B65Buy
ZEAL.COZealand Pharma A/S$3.3B94Strong Buy
GUBRA.COGubra A/S$990M33Sell
BAVA.COBavarian Nordic A/S$2.5B98Strong Buy
CBHD.DEColoplast A/S$16.1B70Buy
SANION.STSaniona AB (publ)$167M80Strong Buy
AMBU-B.COAmbu A/S$2.9B60Hold
GN.COGN Store Nord A/S$2.2B59Hold

Peer medians: ROE 15.9% · P/E 18.5x · Gross margin 82.0%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Ascendis Pharma A/S (ASND): Stock Score Summary

Ascendis Pharma A/S (ASND) has a MoatMap StockRank of 54/100 based on Quality (66/100), Value (24/100), and Momentum (57/100) factor scores. The current signal is HOLD.

Ascendis Pharma A/S is a biopharmaceutical company focused on developing innovative prodrug therapies for rare diseases using its proprietary TransCon technology platform. Its competitive moat is derived from this unique and versatile technology, which enables the creation of sustained-release drug candidates with improved efficacy and safety profiles. The company is a specialized biotech firm, aiming to redefine standards of care for patients with significant unmet medical needs.

Key Financial Metrics

Price$236.72
Market Cap$16.3B
P/E (TTM)18.34
P/E (Forward)21.46
Price/Book51.52
Return on Equity118.8%
Return on Invested Capital-56.6%
Debt/Equity0.31x
Gross Margin91.3%
Operating Margin65.0%
Revenue Growth114.7%
Free Cash Flow$135M

Ascendis Pharma A/S operates in the Biotechnology industry, part of the Healthcare sector (Denmark).

Frequently Asked Questions

What is Ascendis Pharma A/S’s (ASND) StockRank?
MoatMap’s StockRank for Ascendis Pharma A/S (ASND) is 54/100, with a Hold signal. It is a composite of Quality (66), Value (24), and Momentum (57) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Ascendis Pharma A/S have an economic moat?
Ascendis Pharma A/S (ASND) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ascendis Pharma A/S a buy, hold, or sell?
MoatMap’s current signal for Ascendis Pharma A/S (ASND) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Ascendis Pharma A/S in?
Ascendis Pharma A/S (ASND) operates in the Healthcare sector, specifically the Biotechnology industry (Denmark).
Browse all ranked stocksASND deep dive reportAI ChampionsHow we score stocksSense-check another stock